Innova Captab Past Earnings Performance
Past criteria checks 5/6
Innova Captab has been growing earnings at an average annual rate of 24.8%, while the Life Sciences industry saw earnings growing at 9.8% annually. Revenues have been growing at an average rate of 22.9% per year. Innova Captab's return on equity is 21.3%, and it has net margins of 7.8%.
Key information
24.8%
Earnings growth rate
23.6%
EPS growth rate
| Life Sciences Industry Growth | 11.2% |
| Revenue growth rate | 22.9% |
| Return on equity | 21.3% |
| Net Margin | 7.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Innova Captab makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 10,596 | 829 | 801 | 0 |
| 30 Sep 23 | 9,991 | 773 | 682 | 0 |
| 31 Mar 23 | 9,264 | 680 | 563 | 0 |
| 31 Dec 22 | 9,018 | 638 | 552 | 0 |
| 31 Mar 22 | 8,005 | 640 | 416 | 0 |
| 31 Mar 21 | 4,107 | 345 | 226 | 0 |
| 31 Mar 20 | 3,733 | 279 | 203 | 0 |
| 31 Mar 19 | 3,558 | 199 | 182 | 0 |
| 31 Mar 18 | 2,362 | 119 | 122 | 0 |
Quality Earnings: INNOVACAP has high quality earnings.
Growing Profit Margin: INNOVACAP's current net profit margins (7.8%) are higher than last year (7.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: INNOVACAP's earnings have grown significantly by 24.8% per year over the past 5 years.
Accelerating Growth: INNOVACAP's earnings growth over the past year (30%) exceeds its 5-year average (24.8% per year).
Earnings vs Industry: INNOVACAP earnings growth over the past year (30%) exceeded the Life Sciences industry 9.8%.
Return on Equity
High ROE: Whilst INNOVACAP's Return on Equity (21.33%) is high, this metric is skewed due to their high level of debt.